-The Economic Times The increase in India's food subsidy bill after the introduction of the Food Security Act, which will guarantee subsidised grains to a large section of population, could damage the country's financial health, agriculture minister Sharad Pawar said here on Wednesday. The situation is worrying even now, the minister said at the Economic Editors Conference here. "The issue price of grains for ration shops has not been changed for last...
More »SEARCH RESULT
Blame China for the stubborn and high Inflation by Smriti Seth
There is a China hand in India's inflation, one important reason why the steady rise in interest rates may not be cooling the high inflation. About 25% of imported inputs that go into manufacture of goods produced locally are imported from China. In addition, a third of consumer goods imported into India come from China. The inflation in goods exported by China was 10% in July, much higher than its overall...
More »Mining Bill needs refining by Jaideep Mishra
A new draft Bill holds much promise to augment the development delivery mechanism. It is the new mining Bill, 2011, which has specific provisions for earmarking funds for development purposes in the mineral-rich districts that happen to be the regions with high poverty ratios. Revamped mining legislation can boost transparency in the vexed sector that seems much prone to illegality, corruption and extensive fraud. Further, a well-crafted mining law can actually...
More »World hunger report 2011: High, volatile prices set to continue
-FAO Food price volatility featuring high prices is likely to continue and possibly increase, making poor farmers, consumers and countries more vulnerable to poverty and food insecurity, the United Nations' three Rome-based agencies said in the global hunger report published today. Small, import-dependent countries, particularly in Africa, are especially at risk. Many of them still face severe problems following the world food and economic crises of 2006-2008, the UN Food and...
More »Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »